As GLP-1 therapies uptake continue to grow across Canada, pharmacists are supporting more patients using weekly injectable treatments such as Mounjaro, Zepbound, Ozempic, and Wegovy
"TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology"
the Weight Loss: A Critical Distinction This is probably the most important point in this article, and it is one that is frequently lost in general media coverage

Other episodes in this series The Pharmacists Voice Podcast Episode 328, Pronunciation Series Episode 54 (nalmefene) The Pharmacists Voice Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacists Voice Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacists Voice Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacists Voice Podcast episode 180, pronunciation series episode 9 Apretude (cabotegravir) The Pharmacists Voice Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC) The Pharmacists Voice Podcast episode 155, pronunciation series episode 5 Trulicity (dulaglutide) The Pharmacists Voice Podcast episode 148, pronunciation series episode 4 Besponsa (inotuzumab ozogamicin) The Pharmacists Voice Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacists Voice Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacists Voice Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta Thank you for reading my LinkedIn newsletter!
